Hepatic T cell lymphoma after chimeric antigen receptor T cell therapy for myeloma by Joshua Mehr, Mingyi Chen

Subjects: “…Chimeric antigen receptor T‐cell therapy…”
Get full text

Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma by Lina Zhang, Xuxing Shen, Wenjun Yu, Jing Li, Jue Zhang, Run Zhang, Jianyong Li, Lijuan Chen

Subjects: “…Chimeric antigen receptor T-cell therapy…”
Get full text

Differential susceptibility and role for senescence in CART cells based on costimulatory domains by Ismail Can, Elizabeth L. Siegler, Olivia L. Sirpilla, Claudia Manriquez-Roman, Kun Yun, Carli M. Stewart, Jennifer M. Feigin, Makena L. Rodriguez, Omar L. Gutierrez-Ruiz, Ekene J. Ogbodo, Truc N. Huynh, Brooke L. Kimball, Long K. Mai, Mehrdad Hefazi, Lionel Kankeu Fonkoua, Hong Xia, Imene Hamaidi, Berke Alkan, Fatih Sezer, H. Atakan Ekiz, R. Leo Sakemura, Saad S. Kenderian

Subjects: “…Chimeric antigen receptor T cell therapy…”
Get full text

Emerging Clinical Perspectives of Immunotherapy in Triple Negative Breast Cancer: A Comprehensive Review by Sparshita Dey, Sourav Maji, Soutrick Das, Souvik Kar, Sourish Dutta, Moumita Chowdhury

Subjects: “…chimeric antigen receptor t-cell therapy…”
Get full text

Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma by Sahand Saeidpour Masouleh, Kamyar Nasiri, Ava Ostovar Ravari, Mona Saligheh Rad, Kiarash kiani, Ali Sharifi Sultani, Seyedeh Tabasom Nejati, Mohsen Nabi Afjadi

Subjects: Get full text

A bibliometric analysis of challenges and advancements in the integrated application of nanoparticles and chimeric antigen receptor T cell therapy by Yang Gao, Yang Zhou, Xiaolin He, Hongwei Lin, Keying Fang, Qijun Hou, Huafang Wang, Honghao Zhang, Yixi Zhang, Yuhua Li

Subjects: “…Chimeric antigen receptor T cell therapy…”
Get full text

Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus studyResearch in context by Sarah E. Hughes, Foram Khatsuria, Christel McMullan, Karen L. Shaw, Anita Walker, Francesca Kinsella, David Burns, Olalekan L. Aiyegbusi, Elin Haf Davies, John Ansell, Evelyn Chakera, Charles Craddock, Alastair Denniston, Rebecca Lloyd, Paul Ferguson, Ronjon Chakraverty, Melanie Calvert

Subjects: Get full text

Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas by Michael J. Robertson, Eric Vivier, Penny Fang

Subjects: “…CAR (chimeric antigen receptor) T-cell therapy…”
Get full text

Atrial fibrillation is associated with increased in-hospitality mortality during Chimeric Antigen Receptor T-cell therapy hospitalizations: a retrospective cohort study in the Unit... by Nischit Baral, Nabin R. Karki, Daniel A. Ladin, Raja Zaghlol, Mahmoud Ibrahim, Alexander Rabadi, Tarec K. Elajami, Olivia Mechanic, Arvind Kunadi, Joshua D. Mitchell

Subjects: “…Chimeric Antigen Receptor T-cell therapy…”
Get full text

Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models by Anna Qin, Anna Musket, Benjamin Hilton, Johanna Preiszner, Giedre Krenciute, Michael E. Berens, Mingyao Ying, Phillip R. Musich, Qian Xie

Subjects: Get full text

Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy by Goel U, Zanwar S, Cowan AJ, Banerjee R, Khouri J, Dima D

Subjects: Get full text

Chimeric Antigen Receptor T-cell therapy in systemic autoimmune rheumatic diseases: current insights and future prospects by Bong-Woo Lee, Eui-Jong Kwon, Ji Hyeon Ju

Subjects: “…chimeric antigen receptor t-cell therapy…”
Get full text

Research status and prospects of treatment for malignant pleural mesothelioma by ZHAO Kaile, WANG Lei, GENG Jianxiong, CUI Chengwei, YU Yan

Subjects: “…|malignant pleural mesothelioma|medical treatment|immunotherapy|targeted therapy|cancer vaccine therapy|chimeric antigen receptor t cell therapy…”
Get full text

Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis by Danqing Kong, Danqing Kong, Nana Ping, Nana Ping, Qian Zhu, Qian Zhu, Xiao Zhang, Xiao Zhang, Junhong Li, Junhong Li, Rui Zou, Depei Wu, Depei Wu, Zhengming Jin, Zhengming Jin, Changju Qu, Changju Qu

Subjects: Get full text

Breaking boundaries in ankylosing spondylitis: how innovative cell therapies reshape immunity, drive cutting-edge advances, and face future challenges by Minxia Ke, Minxia Ke, Minxia Ke, Wenli Liu, Wenli Liu, Huimin Lu, Xiafei Pan, Mengyang Wu, Nianmin Qi, Zhiqiang Wang, Zhiqiang Wang, Yuehong Wu, Feng Zhang, Feng Zhang

Subjects: Get full text

Approved CAR-T therapies have reproducible efficacy and safety in clinical practice by Daniel Goyco Vera, Hiral Waghela, Mohamed Nuh, Jonathan Pan, Premal Lulla

Subjects: Get full text

Treg cell therapy manufacturability: current state of the art, challenges and new opportunities by Janelle Stoops, Tara Morton, James Powell, Amanda L. Pace, Jeffrey A. Bluestone

Subjects: “…CAR (chimeric antigen receptor) T cell therapy…”
Get full text

CAR-T therapy: pioneering a new era in the treatment of autoimmune diseases by Yuanhao Wu, Luyao Han, Yu Wang, Mengjiao Gu, Yunuo Wang, Jingyue Gao, Hanjing Huang, Chen Li

Subjects: “…chimeric antigen receptor T-cell therapy…”
Get full text

Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observationa... by Rong Shen, Wei‐Guo Cao, Li Wang, Ling‐Shuang Sheng, Yi‐Lun Zhang, Wen Wu, Peng‐Peng Xu, Shu Cheng, Meng‐Ke Liu, Yan Dong, Yue Wang, Xiang‐Qin Weng, Xu‐Feng Jiang, Qi Song, Hong‐Mei Yi, Lei Li, Sheng Chen, Zi‐Xun Yan, Wei‐Li Zhao

Subjects: Get full text

Solid tumour cellular therapy — principles of toxicity management by M. Julve, Y.N.S. Wong, K.H.J. Lim, A.J.S. Furness

Subjects: Get full text